The combined distributor has a new name and ordering platform. The November launch follows the August merger close.
Jazz reports lower quarterly Epidiolex sales but growth across nine months, while a proposed CBD capsule awaits an FDA decision targeted for April 2027.
The announced investment adds a Boonton location to Curaleaf’s New Jersey reach, while leaving the ownership percentage, price and customer-facing changes undisclosed.
The company’s Canadian cannabis plan pairs production transfers with a higher earnings-guidance floor, while keeping the larger savings and certification targets in the future.
The new proposal would preserve a pathway already used by 95 businesses, with separate inventory and records and continuing federal uncertainty.
The company’s October 30 announcement points toward another New York cohort in December, while putting training, compliance and independent retail operations in view.
A newly introduced Michigan bill seeks a one-year pause in the 24% wholesale cannabis tax. It would leave separate retail taxes untouched.
Verano’s October 29 results show higher annual sales and a narrower loss, but a comparison with June gives the quarter a different shape.
A State Street construction update brings Hi! People’s New Haven plans back into focus. A final state license and completed buildout still stand between plans and...
Jushi’s October 28 results pair higher annual sales with a continuing net loss. Comparing the latest quarter with June helps explain the different signals.